PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, experienced a rollercoaster debut on the Nasdaq stock market on Wednesday. After initially rising 5% following its initial public offering (IPO), the stock took an unexpected turn, plummeting 6.25% by the end of the trading session.

The company had priced its IPO at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million. PomDoctor's shares began trading under the ticker symbol "POM" with high hopes, as the company aims to expand its presence in China's growing online healthcare market.

Despite the initial enthusiasm, PomDoctor's stock performance took a sharp downturn during intraday trading. While there was no specific negative news about the company, the sudden drop could be attributed to several factors common in IPO situations. These may include profit-taking by early investors, concerns about the company's valuation, or broader market volatility affecting newly listed stocks. It's also possible that investors are taking a cautious approach to the Chinese tech sector amid ongoing regulatory uncertainties.